Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis
暂无分享,去创建一个
M. Dougados | P. Ravaud | P. Dieppe | L. Paolozzi | A. Le Hénanff | P. Ravaud | T. Pham | A. L. Hénanff | L. Paolozzi
[1] P. Tugwell,et al. Evidence-Based Rheumatology , 2003 .
[2] Arden,et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) , 2003, Annals of the rheumatic diseases.
[3] J. Raynauld,et al. Intra-articular therapy in osteoarthritis , 2003, Postgraduate medical journal.
[4] P. Gishen,et al. A ONE‐YEAR, RANDOMISED, PLACEBO (SALINE) CONTROLLED CLINICAL TRIAL OF 500–730 KDA SODIUM HYALURONATE (HYALGAN®) ON THE RADIOLOGICAL CHANGE IN OSTEOARTHRITIS OF THE KNEE , 2003, International journal of clinical practice.
[5] L. Lohmander,et al. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. , 2002, Rheumatology.
[6] M. Dougados,et al. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. , 2001, Arthritis and rheumatism.
[7] X. Ayral. Injections in the treatment of osteoarthritis. , 2001, Best practice & research. Clinical rheumatology.
[8] J. Block,et al. Efficacy and Safety of Intraarticular Sodium Hyaluronate in Knee Osteoarthritis , 2001 .
[9] J. Block,et al. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. , 2001, Clinical orthopaedics and related research.
[10] Eric Lejeune,et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial , 2001, The Lancet.
[11] R. Moskowitz. Hyaluronic acid supplementation , 2000, Current rheumatology reports.
[12] C. Cooper,et al. EULAR recommendations for the management of knee osteoarthritis , 2001 .
[13] M. Dougados,et al. Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. , 2000, Osteoarthritis and cartilage.
[14] M. Yaron,et al. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. , 2000, Arthritis and rheumatism.
[15] K. Brandt,et al. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence? , 2000, Arthritis and rheumatism.
[16] M. O'regan,et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. , 2000, Clinical therapeutics.
[17] E. Balazs,et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. , 1999, Clinical therapeutics.
[18] S. Trippel. The unmet anti-inflammatory needs in orthopedics. , 1999, American journal of orthopedics.
[19] J. Pelletier,et al. Diacerhein and rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes. , 1998, The Journal of rheumatology.
[20] E. George. Intra-articular hyaluronan treatment for osteoarthritis , 1998, Annals of the rheumatic diseases.
[21] M. Dougados,et al. Variability in knee radiographing: implication for definition of radiological progression in medial knee osteoarthritis , 1998, Annals of the rheumatic diseases.
[22] C. Helmick,et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. , 1998, Arthritis and rheumatism.
[23] R. Maier,et al. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. , 1998, Clinical therapeutics.
[24] J. Pelletier,et al. In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes. , 1998, The Journal of rheumatology.
[25] G. Bouvenot,et al. [Assessment of the placebo effect of symptomatic slow-acting anti-arthritics]. , 1998, Presse medicale.
[26] J. Kirwan,et al. 8 Intra-articular therapy in osteoarthritis , 1997 .
[27] M. Dougados,et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. , 1997, Osteoarthritis and cartilage.
[28] M. Hochberg,et al. A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology. , 1997, Seminars in arthritis and rheumatism.
[29] Nicholas Bellamy,et al. Design and conduct of clinical trials in patients with osteoarthritis : Recommendations from a task force of the Osteoarthritic Research Society , 1996 .
[30] M. Dougados,et al. Knee joint space width measurement: an experimental study of the influence of radiographic procedure and joint positioning. , 1996, British journal of rheumatology.
[31] L. Ryd,et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. , 1996, Annals of the rheumatic diseases.
[32] M. Doherty,et al. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. , 1995, Osteoarthritis and cartilage.
[33] T. Laurent,et al. Functions of hyaluronan. , 1995, Annals of the rheumatic diseases.
[34] L. Ryd,et al. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. A one-year double-blind, placebo-controlled study. , 1994, Arthritis and rheumatism.
[35] M. Dougados,et al. Diacerhein in the treatment of osteoarthritis of the hip. , 1994, Arthritis and rheumatism.
[36] M Lequesne,et al. Guidelines for testing slow acting drugs in osteoarthritis. , 1994, The Journal of rheumatology. Supplement.
[37] D. Blake,et al. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. , 1994, Annals of the rheumatic diseases.
[38] J. Pujol,et al. [Effect of diacerhein (ART 50) on the matrix synthesis and collagenase secretion by cultured joint chondrocytes in rabbits]. , 1993, Revue du rhumatisme.
[39] D. Wilson,et al. The effects of intraarticular administration of hyaluronan in a model of early osteoarthritis in sheep. II. Cartilage composition and proteoglycan metabolism. , 1993, Seminars in arthritis and rheumatism.
[40] J. Peyron. A new approach to the treatment of osteoarthritis: viscosupplementation. , 1993, Osteoarthritis and cartilage.
[41] M. Dougados,et al. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. , 1993, Osteoarthritis and cartilage.
[42] D. Guidolin,et al. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II. Morphological findings. , 1989, Clinical orthopaedics and related research.
[43] R. Cortivo,et al. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. I. Biochemical results. , 1989, Clinical orthopaedics and related research.
[44] M. Dougados,et al. EULAR RECOMMENDATIONS 2003: AN EVIDENCE BASED MEDICINE APPROACH TO THE MANAGEMENT OF KNEE OSTEOARTHRITIS , 2004 .
[45] Thomas J. Schnitzer,et al. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update , 2000 .
[46] R. Moskowitz,et al. A randomized clinical trial of intra-articular sodium hyaluronate in patients with osteoarthritis of the knee: a summary. , 1999, American journal of orthopedics.
[47] D. Willoughby,et al. Effects of diacerhein on granuloma induced cartilage breakdown in the mouse. , 1998, Osteoarthritis and cartilage.
[48] J. Buckwalter,et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. , 1996, Osteoarthritis and cartilage.
[49] M Lequesne,et al. Atlas of individual radiographic features in osteoarthritis. , 1995, Osteoarthritis and cartilage.
[50] R. Moskowitz,et al. Erratum: Guidelines for testing slow acting drugs in osteoarthritis (Journal of Rheumatology (1994) (Suppl 41) 21: (65-71)) , 1994 .
[51] R. Jacoby,et al. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. , 1988, Current medical research and opinion.
[52] U. Martorana,et al. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. , 1987, Pharmatherapeutica.